Table 1 Comparison of antihypertensive drug users and non-users by implants (n=377)
From: Impact of renin-angiotensin system inhibitors and beta-blockers on dental implant stability
Variable | All n | Antihypertensive drug | OR (95% CI) | P | |
|---|---|---|---|---|---|
Users n (%) | Non-users n (%) | ||||
Gender | |||||
 Female | 179 | 23 (50.0) | 156 (47.1) | 1 |  |
 Male | 198 | 23 (50.0) | 175 (52.9) | 0.89 (0.46–1.74) | ns |
Age | |||||
 <70 | 207 | 17 (37.0) | 190 (57.4) | 1 |  |
 ≥70 | 170 | 29 (63.0) | 141 (42.6) | 2.30 (1.17–4.64) | 0.01* |
Implant system | |||||
 STR | 289 | 30 (65.2) | 259 (78.3) | 1 |  |
 SPI | 88 | 16 (34.8) | 72 (21.8) | 1.92 (0.92–3.86) | ns |
Implant diameter | |||||
 4.1 mm | 187 | 20 (43.5) | 167 (50.5) | 1 |  |
 < 4.1 mm | 63 | 3 (6.5) | 60 (18.1) | 0.42 (0.08–1.49) | ns |
 > 4.1 mm | 127 | 23 (50.0) | 104 (31.4) | 1.85 (0.92–3.73) | ns |
Implant length | |||||
 <11 mm | 169 | 25 (54.4) | 144 (43.5) | 1 |  |
 ≥11 mm | 208 | 21 (45.7) | 187 (56.5) | 0.65 (0.33–1.26) | ns |
Localization | |||||
 Maxillary | 225 | 23 (50.0) | 202 (61.0) | 1 |  |
 Mandibular | 152 | 23 (50.0) | 129 (39.0) | 1.57 (0.80–3.05) | ns |
Healing time | |||||
 < 14 weeks | 162 | 20 (43.5) | 142 (42.9) | 1 |  |
 > 14 weeks | 215 | 26 (56.5) | 189 (57.1) | 0.98 (0.50–1.93) | ns |
Bone situation/implant technique | |||||
 Fully ossified situation | 305 | 38 (82.6) | 267 (80.7) | 1 |  |
 Immediate insertion | 41 | 3 (6.5) | 38 (11.5) | 0.56 (0.11–1.89) | ns |
 Internal sinus elevation (immediate insertion)a | 9 | 0 (0.0) | 9 (2.72) | - | - |
 One-step/two-step insertion after internal sinus elevation | 22 | 5 (10.87) | 17 (5.14) | 2.07 (0.56–6.27) | ns |